Clinical Trials Browser

Phase 2 × CLDN18.2 Positive × Gemcitabine × Clear all

NCT07483554 2026-03-19

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Phase 2 Not yet recruiting

Gastrointestinal

CLDN18.2 Positive